Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeuroOne Medical Technologies Corporation - Common Stock (NQ:NMTC)

4.700 -0.050 (-1.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36,362
Open 4.700
Bid (Size) 4.600 (100)
Ask (Size) 5.000 (600)
Prev. Close 4.750
Today's Range 4.500 - 4.740
52wk Range 0.5456 - 5.400
Shares Outstanding 12,000,585
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
EDEN PRAIRIE, MINN. - April 28, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the... 
Via TheNewswire.com
Topics Earnings

Performance

YTD
+451.4%
+451.4%
1 Month
+532.6%
+532.6%
3 Month
+418.3%
+418.3%
6 Month
+498.3%
+498.3%
1 Year
+665.3%
+665.3%

More News

Read More
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
Via TheNewswire.com
News headline image
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
Via NewMediaWire
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update
Via TheNewswire.com
News headline image
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
Via NewMediaWire
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
Via TheNewswire.com
News headline image
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Via NewMediaWire
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Via TheNewswire.com
News headline image
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
Via NewMediaWire
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
Via TheNewswire.com
News headline image
NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology
Via NewMediaWire
NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology
Via TheNewswire.com
News headline image
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time
Via NewMediaWire
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time
Via TheNewswire.com
News headline image
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update
Via NewMediaWire
News headline image
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
Via NewMediaWire
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
Via TheNewswire.com
News headline image
NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time
Via NewMediaWire
NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time
Via TheNewswire.com
News headline image
NeuroOne (NMTC) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
Via NewMediaWire
Topics Intellectual Property
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
Via TheNewswire.com
Topics Intellectual Property
News headline image
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time
Via NewMediaWire
Topics Earnings
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time
Via TheNewswire.com
Topics Earnings

Frequently Asked Questions

Is NeuroOne Medical Technologies Corporation - Common Stock publicly traded?
Yes, NeuroOne Medical Technologies Corporation - Common Stock is publicly traded.
What exchange does NeuroOne Medical Technologies Corporation - Common Stock trade on?
NeuroOne Medical Technologies Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock?
The ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock is NMTC on the Nasdaq Stock Market
What is the current price of NeuroOne Medical Technologies Corporation - Common Stock?
The current price of NeuroOne Medical Technologies Corporation - Common Stock is 4.700
When was NeuroOne Medical Technologies Corporation - Common Stock last traded?
The last trade of NeuroOne Medical Technologies Corporation - Common Stock was at 04/29/26 04:00 PM ET
What is the market capitalization of NeuroOne Medical Technologies Corporation - Common Stock?
The market capitalization of NeuroOne Medical Technologies Corporation - Common Stock is 56.40M
How many shares of NeuroOne Medical Technologies Corporation - Common Stock are outstanding?
NeuroOne Medical Technologies Corporation - Common Stock has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.